Stocks Register•8 days ago
Spruce Biosciences Incorporated develops and commercializes novel therapies for rare endocrine disorders. It is developing Tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from Congenital Adrenal Hyperplasia (CAH), which is in a Phase 2b clinical trial. Spruce Biosciences was incorporated in 2014 and is headquartered in Daly City, CA.
What is Spruce Biosciences's quote symbol?
What is the 52 week high and low for Spruce Biosciences (NASDAQ: SPRB)?
How much is Spruce Biosciences stock worth today?
How much is Spruce Biosciences's stock price per share?
What is Spruce Biosciences's Market Cap?